CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05907018
NCT05907018N/ACompleted

Comparing Phenotypic and Autonomic Physiologic Determinants of Neurocardiogenic Syncope

Children's Hospital Medical Center, Cincinnati·observational·Posted Jun 18, 2023·Updated Jan 29, 2025

In Brief

An observational study for Syncope and 2 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This is a prospective observational pilot study of suitability of autonomic monitoring via the VU-AMS device for prediction of neurocardiogenic syncope (NCS) in children referred to cardiopulmonary exercise testing (CPET) for a diagnosis of syncope. The study population is children referred for CPET to evaluate for neurocardiogenic syncope. The purpose is to describe autonomic function during rest and exercise and determine the positive predictive value of autonomic function measurements against the gold standard for diagnosis of neurocardiogenic syncope, the CPET. Children presenting for CPET with chest pain or who are status post orthotopic heart transplantation will serve as positive and negative controls respectively.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJun 18, 2023
Enrollment StartMay 12, 2023
Primary CompletionOct 23, 2024
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 3.0 years ago